We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Routine Coagulation Testing Methods Compared

By LabMedica International staff writers
Posted on 13 Jun 2012
Coagulation testing can be estimated using two different detection methodologies; one is an optical method and the other a mechanical system. More...


Coagulation analyzers run the range of options, from automated instruments to manual devices, from high-volume processing to low-volume analysis, and from a wide selection of assays to a small, core group of tests.

Scientists at the Memorial Hospital (Istanbul, Turkey) assayed prothrombin time (PT) and activated partial thromboplastin time (aPTT) on the Coag-a-mate MTX II automated photooptical coagulation analyzer and the AMAX 200 automated photo-mechanical coagulation analyzer. A total of 424 patient samples were included in the study during a period of 15 days and plasma from 25 normal healthy individuals was assayed to obtain the geometric means and reference ranges for PT and aPTT for both the MTX II and AMAX 200 instruments which are marketed by TrinityBioTech (Berkeley Heights, NJ, USA).

The results of the coagulation tests showed good precision ranging between 0.7% and 1.8% coefficient of variation. Statistical analysis demonstrated an excellent correlation between the photooptical and mechanical analyzers for PT and aPTT. Plasma samples from 25 healthy normal donors yielded the following reference ranges: for PT, 10.5-12.3 seconds for MTX II and 11.3-13.4 seconds for the AMAX 200. The ranges for the aPTT were 24.5-33.9 seconds for MTX II and 25.5-35.8 seconds for the AMAX 200.

The authors concluded that all data obtained during the study indicate that the patient results obtained by the photooptical detection system are as reliable and statistically equivalent as those obtained using the mechanical detection system. Most notably, they also found that when testing suboptimal samples, such as those with hyperbilirubinemia or lipemia, the photooptical and mechanical detection methods are statistically equivalent. The study was published in the May 2012 issue of the Journal of Clinical Laboratory Analysis.

Related Links:

Memorial Hospital
TrinityBioTech


Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Anterior Nasal Specimen Collection Swabs
53-1195-TFS, 53-0100-TFS, 53-0101-TFS, 53-4582-TFS
Urine Chemistry Control
Dropper Urine Chemistry Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.